(1)	As of December 31, 2019, the Company owns 21.9% of the outstanding equity of DaVinciRe Holdings Ltd.’s ("DaVinciRe") but controls a majority of DaVinciRe's outstanding voting power, and accordingly, DaVinciRe's financial results are consolidated in the Company's financial statements. DaVinci Reinsurance Ltd. is a wholly owned subsidiary of DaVinciRe.

(2)	RenaissanceRe Corporate Capital (UK) Limited is the Lloyd's sponsor of RenaissanceRe Syndicate 1458.

(3)	As of December 31, 2019, the Company owns 12.1% of the outstanding equity of RenaissanceRe Medici Fund Ltd.'s ("RenaissanceRe Medici Fund") but controls a majority of RenaissanceRe Medici Fund's outstanding voting power, and accordingly, RenaissanceRe Medici Fund's financial results are consolidated in the Company's financial statements.

(4)	Upsilon RFO Re Ltd. is considered a variable interest entity and the Company is considered the primary beneficiary of Upsilon RFO Re Ltd., as a result its financial results are consolidated in the Company's financial statements. As of December 31, 2019, the Company's participation in the risks assumed by Upsilon RFO Ltd. was 16.5%.

(5)	Vermeer Reinsurance Ltd. (“Vermeer”) is considered a variable interest entity and the Company is considered the primary beneficiary of Vermeer, as a result its financial results are consolidated in the Company's financial statements.  The Company maintains a majority voting control of Vermeer, while PGGM retains economic benefits.